Marathon Bancorp Reports Over 200% Net Income Growth in Q3 2026
MBBC sits 53% above its 52-week low of $9.9 on elevated volume (14× avg).
Summary
Marathon Bancorp, Inc. reported a substantial increase in net income and EPS for Q3 and the first nine months of fiscal 2026, driven by strong net interest income and loan growth.
Key Events · Earnings and Guidance · MBBC
-
Exceptional Net Income Growth
Net income for the three months ended March 31, 2026, increased by 228.7% to $487,863, and for the nine months, it rose by 282.9% to $1,433,552, significantly outperforming the prior year.
-
Strong EPS Performance
Basic EPS for the quarter increased to $0.18 from $0.05, and year-to-date EPS grew to $0.53 from $0.13, reflecting the substantial earnings improvement.
-
Robust Net Interest Income
Net interest income increased by 40.6% for the quarter and 41.5% for the nine months, primarily due to a 31.0% increase in loan interest income driven by higher average yields and a 15.7% growth in the average loan portfolio balance.
-
Loan Portfolio Expansion
Gross loans increased by $10.9 million (5.4%) to $213.5 million, mainly from growth in one-to-four-family residential and multi-family real estate loans.
Analysis · MBBC · Finance
Marathon Bancorp, Inc. delivered exceptionally strong financial results for the third fiscal quarter and nine months ended March 31, 2026. Net income surged by 228.7% for the quarter and 282.9% year-to-date, driven primarily by robust growth in net interest income and a significant expansion of the loan portfolio. While the company increased its reliance on Federal Home Loan Bank advances to fund loan growth and saw a reduction in credit loss recoveries, the overall performance indicates strong operational execution and asset growth. This positive earnings momentum is particularly notable as the stock is trading near its 52-week high, suggesting investor confidence in the company's trajectory.
At the time of this filing, MBBC was trading at $15.13 on NASDAQ in the Finance sector, with a market capitalization of approximately $44.5M. The 52-week trading range was $9.90 to $15.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.